A Bitter Pill? Researchers Challenge Citrus Aurantium Safety, Efficacy
This article was originally published in The Tan Sheet
The inclusion of Citrus aurantium in weight-loss products is not supported by substantial clinical evidence, researchers conclude in the September issue of Experimental Biology & Medicine
You may also be interested in...
Chattem's impending exit from the bitter orange weight-loss market may be a bellwether for industry, as was the firm's departure from the ephedra business
A 1final rule prohibiting the sale of dietary supplements containing ephedrine alkaloids will become effective April 12, FDA announced Feb. 6
FDA Commissioner Mark McClellan, MD/PhD, said the "framework" for the outright ban of ephedra will be based on substantive scientific evidence as the agency prepares to publish the reg